Colgate-Palmolive (NYSE: CL) CEO gets new stock awards
Colgate-Palmolive (CL) granted its CEO, Noel R. Wallace, 205,197 stock options and 29,649 restricted stock units on September 16, 2026. The options have an exercise price of $87.02 and expire in 2036, vesting over three years. The RSUs vest in equal installments over three years. Wallace's total direct and indirect holdings now exceed 487,000 shares.
How this was made
The 30-second read
Why it matters
The award modestly raises insider ownership but is unlikely to drive significant stock movement.
Market read
A routine insider compensation filing with limited trading relevance.
What to watch
Potential tax implications for the CEO and future dilution if options are exercised.
Background
Colgate‑Palmolive regularly files Form 8‑K disclosures for executive compensation.
Ticker impact
CEO Noel R. Wallace was granted 205,197 stock options and 29,649 RSUs on September 16, 2026, increasing his direct and indirect holdings.
Limited short‑term price impact; potential slight upside if market views the grant as a positive signal.
Grants are routine compensation events; the size is modest relative to market cap, so any price move is likely muted.
Market effects
Minimal impact on consumer staples sector; similar compensation practices are common.
U.S. market only; no broader regional effect.
Low; the news is company‑specific and does not affect global markets.
Counterpoint
The grant could be seen as a defensive move, indicating management expects challenges ahead.
Key entities
- ExecutiveNoel R. Wallace
Chairman, President & CEO of Colgate‑Palmolive


